Cargando…

Hydrocortisone for Preventing Adverse Drug Reactions to Snake Antivenom: A Meta-Analysis

OBJECTIVE: Pretreatment with hydrocortisone (prehydrocortisone) has been used to protect against adverse drug reactions (ADRs) following antivenom administration after snakebite. However, controversial results have been reported in studies evaluating its efficacy. Herein, we conducted a meta-analysi...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Jihua, Wu, Zimeng, Yu, Qiao, Li, Hongyuan, Ji, Pan, Yang, Yanli, Zeng, Xiaoliang, Zheng, Xiaowen, Zhao, Chunling, Zhang, Jianfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9054406/
https://www.ncbi.nlm.nih.gov/pubmed/35498377
http://dx.doi.org/10.1155/2022/6151206
_version_ 1784697179329265664
author Feng, Jihua
Wu, Zimeng
Yu, Qiao
Li, Hongyuan
Ji, Pan
Yang, Yanli
Zeng, Xiaoliang
Zheng, Xiaowen
Zhao, Chunling
Zhang, Jianfeng
author_facet Feng, Jihua
Wu, Zimeng
Yu, Qiao
Li, Hongyuan
Ji, Pan
Yang, Yanli
Zeng, Xiaoliang
Zheng, Xiaowen
Zhao, Chunling
Zhang, Jianfeng
author_sort Feng, Jihua
collection PubMed
description OBJECTIVE: Pretreatment with hydrocortisone (prehydrocortisone) has been used to protect against adverse drug reactions (ADRs) following antivenom administration after snakebite. However, controversial results have been reported in studies evaluating its efficacy. Herein, we conducted a meta-analysis to evaluate the effect of prehydrocortisone on the risk of ADRs. METHODS: We conducted a systematic search of PubMed, Embase, and Cochrane for relevant studies on the literature published up to December 6, 2020, with no language restrictions. Premedications, including hydrocortisone with or without other drugs, were compared with placebo or no premedication. Our primary end point was the risk of ADRs, which was reported as the number of patients who developed ADRs divided by the total number of snakebite patients administered with antivenom separately for the prehydrocortisone and control groups for each study. We evaluated pooled data using of a random-effects model. RESULTS: Among 831 identified studies, 4 were eligible and included in our analysis (N = 1348 participants). Upon combining all eight comparisons from the four selected studies, the overall pooled odds ratio (OR) for ADRs was 0.47 (95% CI 0.19, 1.17; p=0.11; I(2) = 68%). When the analysis was restricted to only articles using hydrocortisone with other drugs, the pooled OR was 0.19 (95% CI 0.05, 0.75; p=0.02; I(2) = 55%). The result was not statistically significant when the analysis was restricted to studies using prehydrocortisone alone, or randomized controlled designs, or cohorts. Our study was limited by heterogeneity, quality, and a paucity of data. CONCLUSIONS: The findings in this study revealed that prehydrocortisone alone was ineffective. However, the substantial beneficial effect of prehydrocortisone combinations with premedications (injectable antihistamines or adrenaline) used against ADRs cannot be excluded. Therefore, the use of prehydrocortisone combinations with premedications (injectable antihistamines or adrenaline) as a prophylaxis may reduce the ADRs to antivenom.
format Online
Article
Text
id pubmed-9054406
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-90544062022-04-30 Hydrocortisone for Preventing Adverse Drug Reactions to Snake Antivenom: A Meta-Analysis Feng, Jihua Wu, Zimeng Yu, Qiao Li, Hongyuan Ji, Pan Yang, Yanli Zeng, Xiaoliang Zheng, Xiaowen Zhao, Chunling Zhang, Jianfeng Emerg Med Int Research Article OBJECTIVE: Pretreatment with hydrocortisone (prehydrocortisone) has been used to protect against adverse drug reactions (ADRs) following antivenom administration after snakebite. However, controversial results have been reported in studies evaluating its efficacy. Herein, we conducted a meta-analysis to evaluate the effect of prehydrocortisone on the risk of ADRs. METHODS: We conducted a systematic search of PubMed, Embase, and Cochrane for relevant studies on the literature published up to December 6, 2020, with no language restrictions. Premedications, including hydrocortisone with or without other drugs, were compared with placebo or no premedication. Our primary end point was the risk of ADRs, which was reported as the number of patients who developed ADRs divided by the total number of snakebite patients administered with antivenom separately for the prehydrocortisone and control groups for each study. We evaluated pooled data using of a random-effects model. RESULTS: Among 831 identified studies, 4 were eligible and included in our analysis (N = 1348 participants). Upon combining all eight comparisons from the four selected studies, the overall pooled odds ratio (OR) for ADRs was 0.47 (95% CI 0.19, 1.17; p=0.11; I(2) = 68%). When the analysis was restricted to only articles using hydrocortisone with other drugs, the pooled OR was 0.19 (95% CI 0.05, 0.75; p=0.02; I(2) = 55%). The result was not statistically significant when the analysis was restricted to studies using prehydrocortisone alone, or randomized controlled designs, or cohorts. Our study was limited by heterogeneity, quality, and a paucity of data. CONCLUSIONS: The findings in this study revealed that prehydrocortisone alone was ineffective. However, the substantial beneficial effect of prehydrocortisone combinations with premedications (injectable antihistamines or adrenaline) used against ADRs cannot be excluded. Therefore, the use of prehydrocortisone combinations with premedications (injectable antihistamines or adrenaline) as a prophylaxis may reduce the ADRs to antivenom. Hindawi 2022-04-22 /pmc/articles/PMC9054406/ /pubmed/35498377 http://dx.doi.org/10.1155/2022/6151206 Text en Copyright © 2022 Jihua Feng et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Feng, Jihua
Wu, Zimeng
Yu, Qiao
Li, Hongyuan
Ji, Pan
Yang, Yanli
Zeng, Xiaoliang
Zheng, Xiaowen
Zhao, Chunling
Zhang, Jianfeng
Hydrocortisone for Preventing Adverse Drug Reactions to Snake Antivenom: A Meta-Analysis
title Hydrocortisone for Preventing Adverse Drug Reactions to Snake Antivenom: A Meta-Analysis
title_full Hydrocortisone for Preventing Adverse Drug Reactions to Snake Antivenom: A Meta-Analysis
title_fullStr Hydrocortisone for Preventing Adverse Drug Reactions to Snake Antivenom: A Meta-Analysis
title_full_unstemmed Hydrocortisone for Preventing Adverse Drug Reactions to Snake Antivenom: A Meta-Analysis
title_short Hydrocortisone for Preventing Adverse Drug Reactions to Snake Antivenom: A Meta-Analysis
title_sort hydrocortisone for preventing adverse drug reactions to snake antivenom: a meta-analysis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9054406/
https://www.ncbi.nlm.nih.gov/pubmed/35498377
http://dx.doi.org/10.1155/2022/6151206
work_keys_str_mv AT fengjihua hydrocortisoneforpreventingadversedrugreactionstosnakeantivenomametaanalysis
AT wuzimeng hydrocortisoneforpreventingadversedrugreactionstosnakeantivenomametaanalysis
AT yuqiao hydrocortisoneforpreventingadversedrugreactionstosnakeantivenomametaanalysis
AT lihongyuan hydrocortisoneforpreventingadversedrugreactionstosnakeantivenomametaanalysis
AT jipan hydrocortisoneforpreventingadversedrugreactionstosnakeantivenomametaanalysis
AT yangyanli hydrocortisoneforpreventingadversedrugreactionstosnakeantivenomametaanalysis
AT zengxiaoliang hydrocortisoneforpreventingadversedrugreactionstosnakeantivenomametaanalysis
AT zhengxiaowen hydrocortisoneforpreventingadversedrugreactionstosnakeantivenomametaanalysis
AT zhaochunling hydrocortisoneforpreventingadversedrugreactionstosnakeantivenomametaanalysis
AT zhangjianfeng hydrocortisoneforpreventingadversedrugreactionstosnakeantivenomametaanalysis